Physician

Ankur Lodha, M.D

According to 2025 Medicare claims, Ankur Lodha, M.D (NPI: 1598951436) practices interventional cardiology in the Lafayette, LA market, with the plurality of this provider's patient population coming from Lafayette, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70503-2632. Lodha is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Lodha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,306 traditional Medicare patients, billed 13,374 HCPCS/CPT codes, and received $1,042,063 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 12,123 prescription claims across 1,310 beneficiaries totaling $1,377,469 in drug costs, led by Eliquis (Apixaban). DME data shows 24 claims. Open Payments data shows 275 records totaling $191,696. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $177,814 to $1,377,469. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,077 and ending at $20,011.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,135	8,708	$548,036
2016	3,963	10,889	$900,732
2017	5,346	17,803	$1,189,177
2018	3,630	21,966	$1,907,624
2019	3,284	18,147	$1,727,917
2020	3,679	17,513	$1,562,431
2021	1,938	12,994	$1,309,165
2022	1,304	12,284	$1,239,132
2023	1,745	13,779	$1,339,320
2024	3,306	13,374	$1,042,063

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	439	4,143	$177,814
2016	621	6,417	$347,628
2017	717	7,180	$373,646
2018	818	7,048	$423,228
2019	879	7,153	$552,408
2020	848	5,933	$558,274
2021	876	6,108	$610,227
2022	972	6,840	$693,668
2023	1,244	9,768	$1,053,192
2024	1,310	12,123	$1,377,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,560
2016	N/R	12	$1,081
2017	N/R	51	$2,083
2018	30	62	$21,440
2019	76	91	$52,541
2020	N/R	13	$342
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	23	35	$17,159
2024	N/R	24	$1,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	406	426	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	751	1,189	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	761	1,266	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	718	956	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,309	3,057	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	645	29,955	$574,032
Entresto	Sacubitril/Valsartan	267	11,616	$259,806
Xarelto	Rivaroxaban	262	12,778	$237,636
Repatha Sureclick	Evolocumab	137	4,850	$95,275
Farxiga	Dapagliflozin Propanediol	39	1,350	$25,445

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$817
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$399

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	264	$134,917	ShockWave Medical, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$56,780	Terumo Medical Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$35,000	Vantis Vascular, Inc.

Explore More Providers

FAQ

What Medicare data is available for Ankur Lodha, M.D?

Tedicare shows public-source Medicare data for Ankur Lodha, M.D (NPI 1598951436), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ankur Lodha, M.D have ACO affiliation data?

Ankur Lodha, M.D is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Ankur Lodha, M.D?

Ankur Lodha, M.D is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Ankur Lodha, M.D have Open Payments data?

Ankur Lodha, M.D has 275 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.